Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

Outwitting & Outwaiting ARV Resistance

In the best health news of the year (so far!), a new New England Journal of Medicine study has found that delaying the start of a nevirapine-based antiretroviral therapy by six months can prevent the development of drug resistance in HIV-positive women who took single-dose nevirapine during labor to prevent mother-to-child transmission of the virus.

Outwitting & Outwaiting ARV Resistance

In the best health news of the year (so far!), a new New England Journal of Medicine study has found that delaying the start of a nevirapine-based antiretroviral therapy by six months can prevent the development of drug resistance in HIV-positive women who took single-dose nevirapine during labor to prevent mother-to-child transmission of the virus.

Baltimore Sun Op-Ed Endorsing AMC Pilot

Check out the Baltimore Sun op-ed by Orin Levine (Executive Director of PneumoADIP) and Michael Klag (Dean of the Johns Hopkins Bloomberg School of Public Health) endorsing a pilot advance market commitment for a pneumococcal vaccine. And for more information, see GAVI's new AMC fact sheet (.pdf).

Pages